Hemorrhagic fever

Common Name(s)

Hemorrhagic fever

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Hemorrhagic fever" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Hemorrhagic fever" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Hemorrhagic fever" returned 537 free, full-text research articles on human participants. First 3 results:

Sequential determination of serum viral titers, virus-specific IgG antibodies, and TNF-α, IL-6, IL-10, and IFN-γ levels in patients with Crimean-Congo hemorrhagic fever.
 

Author(s): Safak Kaya, Nazif Elaldi, Ayhan Kubar, Nevcihan Gursoy, Meral Yilmaz, Gulderen Karakus, Turabi Gunes, Zubeyde Polat, Mustafa Gokhan Gozel, Aynur Engin, Ilyas Dokmetas, Mehmet Bakir, Neziha Yilmaz, Mehmet Sencan

Journal:

 

Although there have been a number of studies on the pathogenesis of Crimean-Congo hemorrhagic fever (CCHF) recently, knowledge on this topic is still insufficient. This study aims to reveal the kinetics of serum CCHF virus (CCHFV) titers, serum levels of anti-CCHFV immunoglobulin ...

Last Updated: 15 Aug 2014

Go To URL
Dengue hemorrhagic fever: a rare cause of pituitary apoplexy.
 

Author(s): Sudhansu Sekhar Mishra, Souvagya Panigrahi, Srikanta Das

Journal: Neurol India. ;62(1):92-3.

 

Last Updated: 10 Mar 2014

Go To URL
A host-oriented inhibitor of Junin Argentine hemorrhagic fever virus egress.
 

Author(s): Jianhong Lu, Ziying Han, Yuliang Liu, Wenbo Liu, Michael S Lee, Mark A Olson, Gordon Ruthel, Bruce D Freedman, Ronald N Harty

Journal: J. Virol.. 2014 May;88(9):4736-43.

 

There are currently no U.S. Food and Drug Administration (FDA)-approved vaccines or therapeutics to prevent or treat Argentine hemorrhagic fever (AHF). The causative agent of AHF is Junin virus (JUNV); a New World arenavirus classified as a National Institute of Allergy and Infectious ...

Last Updated: 7 Apr 2014

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Hemorrhagic fever" returned 31 free, full-text review articles on human participants. First 3 results:

Role of cognitive parameters in dengue hemorrhagic fever and dengue shock syndrome.
 

Author(s): Jih-Jin Tsai, Kulkanya Chokephaibulkit, Po-Chih Chen, Li-Teh Liu, Hui-Mien Hsiao, Yu-Chih Lo, Guey Chuen Perng

Journal:

 

Dengue is becoming recognized as one of the most important vector-borne human diseases. It is predominant in tropical and subtropical zones but its geographical distribution is progressively expanding, making it an escalating global health problem of today. Dengue presents with spectrum ...

Last Updated: 16 Dec 2013

Go To URL
The role of endothelial activation in dengue hemorrhagic fever and hantavirus pulmonary syndrome.
 

Author(s): Christina F Spiropoulou, Anon Srikiatkhachorn

Journal: Virulence. 2013 Aug;4(6):525-36.

 

The loss of the endothelium barrier and vascular leakage play a central role in the pathogenesis of hemorrhagic fever viruses. This can be caused either directly by the viral infection and damage of the vascular endothelium, or indirectly by a dysregulated immune response resulting ...

Last Updated: 27 Aug 2013

Go To URL
Targeting virulence mechanisms for the prevention and therapy of arenaviral hemorrhagic fever.
 

Author(s): Lisa McLay, Aftab Ansari, Yuying Liang, Hinh Ly

Journal: Antiviral Res.. 2013 Feb;97(2):81-92.

 

A number of arenaviruses are pathogenic for humans, but they differ significantly in virulence. Lassa virus, found in West Africa, causes severe hemorrhagic fever (HF), while the other principal Old World arenavirus, lymphocytic choriomeningitis virus, causes mild illness in persons ...

Last Updated: 4 Feb 2013

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Phase 2a Immunogenicity Study of Hantaan/Puumala Virus DNA Vaccine for Prevention of Hemorrhagic Fever
 

Status: Recruiting

Condition Summary: Hemorrhagic Fever With Renal Syndrome

 

Last Updated: 12 Sep 2014

Go to URL
Phase 1 Trial of Ebola Vaccine in Mali
 

Status: Not yet recruiting

Condition Summary: Ebola Virus Disease; Hemorrhagic Fever

 

Last Updated: 14 Oct 2014

Go to URL
Immunologic Mechanisms of Immune Interference and/or Cross-Neutralizing Immunity After CYD Tetravalent Dengue Vaccine
 

Status: Recruiting

Condition Summary: Dengue; Dengue Fever; Dengue Hemorrhagic Fever

 

Last Updated: 18 Sep 2014

Go to URL